Chromium(III) picolinate

We are Chromium(III) picolinate CAS:14639-25-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Other name: 
Chromium Picolinate

CAS No.: 14639-25-9

Molecular Weight: 418.33

 

Characters: Small purple-red crystalline powder, stable at room temperature, slightly soluble in water, insoluble in ethanol, in which trivalent chromium as chromium.
 

Specifications:

Chromium Picolinate	USP31	Export of pharmaceutical grade
Item	Spec.	Spec.
Purity[Cr(C6H4NO2)3dry]%	98.0-102.0	≥99.0
Chromium[Cr] %	—	≥12.3
Chloride[Cl] %	≤0.06	≤0.06
Lead [Pb] %	—	≤0.005
Arsenic[AS] %	—	≤0.0005
Loss on drying(105℃)%	≤4	≤0.5
Fineness(150μm)%	—	≥95
Sulfate(SO4)%	≤0.2	≤0.2

Chromium Picolinate	Feed grade	Feed grade（1‰hromium）
Item	Spec.	Spec.
Purity[Cr(C6H4NO2)3 dry]%	≥98.5	≥0.08
Chromium[Cr] %	≥12.18	0.09-0.11
Lead [Pb] %	≤0.005	≤0.001
Arsenic[AS] %	≤0.0005	≤0.0005
Loss on drying(105℃)%	≤0.5	≤2.0
Fineness(150μm)%	≥90	≥90
Density(g/ml)%	≤0.45	—

Product Usage: The cell membrane can be passed directly on tissue cells, enhance insulin activity, improve glucose metabolism in the human body to enhance immune function and increase stress and reduce disease; to promote animal growth rate, the promotion of protein synthesis. The promotion of gonadal development, improve the quality of ovulation, improve reproductive performance; reduced ketone body fat, increase lean meat ratio, meat quality significantly improved. Improve the breeder egg fertilization rate and egg production rate quality.

Packaging: 25kg cardboard drum, lined with double plastic bags.

Storage Precautions: Stored in a dry, ventilated, cool warehouse, against moisture and fire.

Related News: Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.2-bromo-3-fluoro-6-picolina CAS:374633-36-0 “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.4-mercapto-4-methylpentan-2-one Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.2-bromo-5-fluoro-4-metil-3-nitropiridina CAS:917918-84-4 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.